Top compounds associated with response to POLR2C


Feature Type Standardized
Nominal ANOVA
mRNA BRD1812 CTRPv2 pan-cancer AAC -0.14 7e-05
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA CCT036477 CTRPv2 pan-cancer AAC -0.12 0.0004
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0006
mRNA linifanib GDSC1000 pan-cancer AAC -0.12 0.0006
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0006
mRNA neratinib CTRPv2 pan-cancer AAC -0.12 0.0009
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.001
Download CSV